Financial News Directly From The Source Latest Reports Latest Research

IGEA Pharma N.V.: IGEA discloses its half-year figures 2023

Advanced Bitcoin Technologies AG mit positivem EBITDA und strategischen Fortschritten im 1. Halbjahr 2023

Adtran Networks SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Adtran Holdings, Inc.: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Abivax files registration statement for proposed initial public offering in the United States

Northern Data AG: ART Beteiligungs Management GmbH, Pledge in connection with a loan transaction of 37,015 convertible bonds of Northern Data AG with a nominal value of EUR 1,000.00 each

Northern Data AG: ART Beteiligungs Management GmbH, Acquisition of new convertible bonds to be issued

BP p.l.c.: Release of a capital market information

Rubean AG: BMK Holding GmbH, Kauf

Rubean AG: BMK Holding GmbH, Kauf

Bybit and Max Verstappen Extend Grand Prix Triumph with Unforgettable Fan Celebration in Japan Source: Bybit

Rubean AG: BMK Holding GmbH, Kauf

Silver Lake announces successful closing of its tender offer for Software AG and has now secured more than 87% of Software AG

Abivax announces the release of its 2023 half-year financial report

Rubean AG: Jochen Pielage, Kauf

Adtran Holdings, Inc.: Release according to Article 50 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

ESPG annouces loan of 10.4 million euro and start of new bond conditions

NEON EQUITY AG with successful 1st half-year 2023 / EBT at 5.79 million Euro

publity AG’s figures for the first half of 2023 put it on course to break even for the year as a whole

HORNBACH Holding AG & Co. KGaA: AB-Holding GmbH, buy

Bilfinger SE: Dr. Thomas Schulz, buy

Bilfinger SE: Dr. Thomas Schulz, buy

Tonkens Agrar AG erzielt im Geschäftsjahr 2022/2023 ein Konzernergebnis vor Steuern von 1,9 Mio. EUR

Bilfinger SE: Dr. Thomas Schulz, buy